Sergey Bogolyubov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sergey Bogolyubov has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Elizaveta E. Bragina
Federal State Budgetary Scientific Institution “Research Centre for Medical Genetics” (RCMG), 1 Moskvorechye St., 115522 Moscow, Russia
3 shared publications - Vyacheslav Borisovich Chernykh
Research Centre for Medical Genetics; N.I. Pirogov Russian National Research Medical University
3 shared publications - I. I. Vityazeva
Endocrinology Research Centre
2 shared publications - Olga Aleksandrovna Solovova
Research Centre for Medical Genetics
2 shared publications - S. Sh. Khayat
Research Centre for Medical Genetics
2 shared publications - T. B. Milovidova
Research Centre for Medical Genetics, 115522 Moscow, Russia
2 shared publications
Latest Publications
- 3 July 2026
- Published by Media Sphere Publishing Group in Russian Journal of Human Reproduction
- Vol. 32 (3)
Evaluation of the effect of the combined antioxidant preparation Megaspermin Maca on spermatogenesis parameters and DNA fragmentation levels in men with idiopathic pathospermia
Male factor infertility remains one of the leading causes of reduced reproductive potential in couples, accounting for up to 50% of infertility cases. Traditional semen analysis parameters do not always reflect the true fertility status, as a significant proportion of men with normal ejaculate parameters are diagnosed with impaired sperm genetic integrity. One of the key mechanisms of sperm damage is oxidative stress. Consequently, pathogenetically substantiated complex antioxidant and metabolic support for spermatogenesis is of particular interest. Objective. To evaluate changes in spermatogenesis parameters and sperm DNA fragmentation levels in men with idiopathic pathospermia following administration of a combined antioxidant complex. Material and methods. A multicenter observational study included 118 men aged 25—55 years with idiopathic pathospermia. Participants received a combined antioxidant complex for 90 days. The following parameters were assessed: ejaculate volume, sperm concentration, progressive motility, sperm morphology and the level of DNA fragmentation measured by the TUNEL assay. Semen analysis was performed before the initiation of therapy and after three months of therapy. Results. Administration of the studied complex was associated with statistically significant improvement in the main parameters (volume, concentration, progressive motility and sperm morphology) and a reduction in DNA fragmentation levels (p<0.001). Positive dynamics of the corresponding parameters were noted in subgroups of patients with baseline oligozoospermia, asthenozoospermia and teratozoospermia (p<0.05). Conclusions. The use of combined antioxidant complex was associated with a statistically significant improvement in spermatogenesis parameters and a decrease in sperm DNA fragmentation levels in men with idiopathic pathospermia. The obtained findings suggest that pathogenetically oriented nutritional antioxidant support may represent a potentially promising approach for the management of spermatogenesis disorders. However, the observational design of the study and the absence of a control group limit the possibility of causal interpretation of the observed changes. Further randomized controlled studies are required to further evaluate these findings and their potential clinical significance.
- 3 July 2026
- Published by Media Sphere Publishing Group in Russian Journal of Human Reproduction
- Vol. 32 (3)
Evaluation of the effect of the combined antioxidant preparation Megaspermin Maca on spermatogenesis parameters and DNA fragmentation levels in men with idiopathic pathospermia
Male factor infertility remains one of the leading causes of reduced reproductive potential in couples, accounting for up to 50% of infertility cases. Traditional semen analysis parameters do not always reflect the true fertility status, as a significant proportion of men with normal ejaculate parameters are diagnosed with impaired sperm genetic integrity. One of the key mechanisms of sperm damage is oxidative stress. Consequently, pathogenetically substantiated complex antioxidant and metabolic support for spermatogenesis is of particular interest. Objective. To evaluate changes in spermatogenesis parameters and sperm DNA fragmentation levels in men with idiopathic pathospermia following administration of a combined antioxidant complex. Material and methods. A multicenter observational study included 118 men aged 25—55 years with idiopathic pathospermia. Participants received a combined antioxidant complex for 90 days. The following parameters were assessed: ejaculate volume, sperm concentration, progressive motility, sperm morphology and the level of DNA fragmentation measured by the TUNEL assay. Semen analysis was performed before the initiation of therapy and after three months of therapy. Results. Administration of the studied complex was associated with statistically significant improvement in the main parameters (volume, concentration, progressive motility and sperm morphology) and a reduction in DNA fragmentation levels (p<0.001). Positive dynamics of the corresponding parameters were noted in subgroups of patients with baseline oligozoospermia, asthenozoospermia and teratozoospermia (p<0.05). Conclusions. The use of combined antioxidant complex was associated with a statistically significant improvement in spermatogenesis parameters and a decrease in sperm DNA fragmentation levels in men with idiopathic pathospermia. The obtained findings suggest that pathogenetically oriented nutritional antioxidant support may represent a potentially promising approach for the management of spermatogenesis disorders. However, the observational design of the study and the absence of a control group limit the possibility of causal interpretation of the observed changes. Further randomized controlled studies are required to further evaluate these findings and their potential clinical significance.
- Open Access
A Novel Variant of the ACTRT1 Gene Is Potentially Associated with Oligoasthenoteratozoospermia, Acrosome Detachment, and Fertilization Failure
Background: Male infertility is a common reproductive disorder, affecting about 7% of men in the general population. Despite its prevalence, the cause of infertility is often unknown. This case report presents the results of a comprehensive evaluation of a patient with severe oligoasthenoteratozoospermia and primary infertility. Methods: The patient underwent clinical, andrological, and genetic examinations, including semen analysis, transmission electron microscopy, cytogenetic examination, molecular analysis of the AZF locus and the CFTR gene, whole-exome sequencing, and Sanger sequencing. Results: Semen analysis revealed severe oligoasthenoteratozoospermia. Transmission electron microscopy showed acrosome detachment from the nucleus in 49% of the spermatozoa. A high percentage (54%) of spermatozoa with insufficiently condensed (“immature”) chromatin was also observed. No chromosomal abnormalities, Y chromosome microdeletions, or pathogenic CFTR gene variants were identified. Whole-exome sequencing revealed a novel c.821G>C variant (chrX:127185365G>C; NM_138289.4) in the ACTRT1 gene (Xq25). This variant was hemizygous in the patient and heterozygous in his mother, as determined by Sanger sequencing. According to the ACMG guidelines (PM2, PP3), this missense variant in the ACTRT1 gene was classified as a variant of uncertain clinical significance (VUS). Amino acid conservation and 3D protein modeling predict that the identified variant has a deleterious effect on the protein. Conclusions: This study suggests a potential link between a novel ACTRT1 variant and a specific teratozoospermia phenotype. Further functional studies are needed to confirm this association and determine the role of the gene in X-linked male infertility.
Open AccessA Novel Variant of the ACTRT1 Gene Is Potentially Associated with Oligoasthenoteratozoospermia, Acrosome Detachment, and Fertilization Failure
Background: Male infertility is a common reproductive disorder, affecting about 7% of men in the general population. Despite its prevalence, the cause of infertility is often unknown. This case report presents the results of a comprehensive evaluation of a patient with severe oligoasthenoteratozoospermia and primary infertility. Methods: The patient underwent clinical, andrological, and genetic examinations, including semen analysis, transmission electron microscopy, cytogenetic examination, molecular analysis of the AZF locus and the CFTR gene, whole-exome sequencing, and Sanger sequencing. Results: Semen analysis revealed severe oligoasthenoteratozoospermia. Transmission electron microscopy showed acrosome detachment from the nucleus in 49% of the spermatozoa. A high percentage (54%) of spermatozoa with insufficiently condensed (“immature”) chromatin was also observed. No chromosomal abnormalities, Y chromosome microdeletions, or pathogenic CFTR gene variants were identified. Whole-exome sequencing revealed a novel c.821G>C variant (chrX:127185365G>C; NM_138289.4) in the ACTRT1 gene (Xq25). This variant was hemizygous in the patient and heterozygous in his mother, as determined by Sanger sequencing. According to the ACMG guidelines (PM2, PP3), this missense variant in the ACTRT1 gene was classified as a variant of uncertain clinical significance (VUS). Amino acid conservation and 3D protein modeling predict that the identified variant has a deleterious effect on the protein. Conclusions: This study suggests a potential link between a novel ACTRT1 variant and a specific teratozoospermia phenotype. Further functional studies are needed to confirm this association and determine the role of the gene in X-linked male infertility.
- Open Access
- 13 November 2025
- Published by MDPI AG in Preprints.org
A Novel Variant of the ACTRT1 Gene is Potentially Associated with Oligoasthenoteratozoospermia, Acrosome Detachment, and Fertilization Failure
Background: Male infertility is a common reproductive disorder, affecting about 7% of men in the general population. Despite its prevalence, the cause of infertility is often unknown. This case report presents the results of a comprehensive evaluation of a patient with severe oligoteratozoospermia and primary infertility. Methods: The patient underwent clinical, andrological, and genetic examinations, including semen analysis, transmission electron microscopy, cytogenetic examination, molecular analysis of the AZF locus and the CFTR gene, whole exome sequencing and Sanger sequencing. Results: Semen analysis revealed severe oligoasthenoteratozoospermia. Transmission electron microscopy showed acrosome detachment from the nucleus in 49% of the spermatozoa. A high percentage of spermatozoa with insufficiently condensed ("immature") chromatin (54%) was also observed. No chromosomal abnormalities, Y chromosome microdeletions, or pathogenic CFTR gene variants were identified. Whole exome sequencing revealed a novel c.821G>C variant (chrX:127185365G>C; NM_138289.4) in the ACTRT1 gene (Xq25). This variant was hemizygous in the patient and heterozygous in his mother, as determined by Sanger sequencing. According to the ACMG guidelines (PM2, PP3), this missense variant in the ACTRT1 gene was classified as a variant of uncertain clinical significance (VUS). Amino acid conservation and 3D protein modeling predict that the identified variant has a deleterious effect on the protein. Conclusions: This study demonstrates that hemizygous variants of the ACTRT1 gene can cause X-linked specific teratozoospermia characterized by acrosome detachment from the sperm nucleus. These findings underscore the importance of genetic testing for infertile men with specific morphological abnormalities.
- 13 November 2025
- Published by MDPI AG in Preprints.org
Open AccessA Novel Variant of the ACTRT1 Gene is Potentially Associated with Oligoasthenoteratozoospermia, Acrosome Detachment, and Fertilization Failure
Background: Male infertility is a common reproductive disorder, affecting about 7% of men in the general population. Despite its prevalence, the cause of infertility is often unknown. This case report presents the results of a comprehensive evaluation of a patient with severe oligoteratozoospermia and primary infertility. Methods: The patient underwent clinical, andrological, and genetic examinations, including semen analysis, transmission electron microscopy, cytogenetic examination, molecular analysis of the AZF locus and the CFTR gene, whole exome sequencing and Sanger sequencing. Results: Semen analysis revealed severe oligoasthenoteratozoospermia. Transmission electron microscopy showed acrosome detachment from the nucleus in 49% of the spermatozoa. A high percentage of spermatozoa with insufficiently condensed ("immature") chromatin (54%) was also observed. No chromosomal abnormalities, Y chromosome microdeletions, or pathogenic CFTR gene variants were identified. Whole exome sequencing revealed a novel c.821G>C variant (chrX:127185365G>C; NM_138289.4) in the ACTRT1 gene (Xq25). This variant was hemizygous in the patient and heterozygous in his mother, as determined by Sanger sequencing. According to the ACMG guidelines (PM2, PP3), this missense variant in the ACTRT1 gene was classified as a variant of uncertain clinical significance (VUS). Amino acid conservation and 3D protein modeling predict that the identified variant has a deleterious effect on the protein. Conclusions: This study demonstrates that hemizygous variants of the ACTRT1 gene can cause X-linked specific teratozoospermia characterized by acrosome detachment from the sperm nucleus. These findings underscore the importance of genetic testing for infertile men with specific morphological abnormalities.
- Open Access
- 5 July 2020
- Published by "MedINK" Publishing House in Andrology and Genital Surgery
- Vol. 21 (2) , 36-43
Obesity as a factor in spermatogenesis disorders (experimental study)
Intr oduction. In recent years, the effects of obesity on male fertility have been extensively investigated. The results of existing studies are extremely contradictory. The study objective was to determine the effect of obesity on the male reproductive system using the biological model of laboratory rats as an example. Materials and methods. In vivo modeling of diet-induced obesity. The study was conducted on 22 laboratory sexually mature white rats weighing 140–160 g. The animals were divided into two groups: 1 control (10 animals) and 2 rats with diet-induced obesity (12 animals). After 12 weeks, the animals were removed from the experiment. All rats underwent: calculation of the Lee index (body mass index in rats), determination of the concentration and viability of spermatozoa in a suspension of sperm from the epididymis, determination of glucose level of total cholesterol and triglycerides in the blood, study of sperm DNA fragmentation, histological examination testis: calculating the crosssectional area of the seminiferous tubule; determination of the number of non-functioning tubules and tubules with desquamated spermiogenic epithelium; determination of the average spermatogenesis index. Results. In the study groups there were no differences in glucose and total cholesterol levels. However, a statistically significant, significant difference in the level of triglycerides in the blood was revealed. The concentration of sperm and their viability in the studied groups did not differ. The level of sperm DNA fragmentation in the experimental group is significantly higher than in the control group (31.5 ± 10.1 and ± 1.4 %, respectively, p Conclusion. Diet-induced obesity causes impaired spermatogenesis, and damage to the sperm genetic material in male white rats.
- 5 July 2020
- Published by "MedINK" Publishing House in Andrology and Genital Surgery
- Vol. 21 (2) , 36-43
Open AccessObesity as a factor in spermatogenesis disorders (experimental study)
Intr oduction. In recent years, the effects of obesity on male fertility have been extensively investigated. The results of existing studies are extremely contradictory. The study objective was to determine the effect of obesity on the male reproductive system using the biological model of laboratory rats as an example. Materials and methods. In vivo modeling of diet-induced obesity. The study was conducted on 22 laboratory sexually mature white rats weighing 140–160 g. The animals were divided into two groups: 1 control (10 animals) and 2 rats with diet-induced obesity (12 animals). After 12 weeks, the animals were removed from the experiment. All rats underwent: calculation of the Lee index (body mass index in rats), determination of the concentration and viability of spermatozoa in a suspension of sperm from the epididymis, determination of glucose level of total cholesterol and triglycerides in the blood, study of sperm DNA fragmentation, histological examination testis: calculating the crosssectional area of the seminiferous tubule; determination of the number of non-functioning tubules and tubules with desquamated spermiogenic epithelium; determination of the average spermatogenesis index. Results. In the study groups there were no differences in glucose and total cholesterol levels. However, a statistically significant, significant difference in the level of triglycerides in the blood was revealed. The concentration of sperm and their viability in the studied groups did not differ. The level of sperm DNA fragmentation in the experimental group is significantly higher than in the control group (31.5 ± 10.1 and ± 1.4 %, respectively, p Conclusion. Diet-induced obesity causes impaired spermatogenesis, and damage to the sperm genetic material in male white rats.
- Open Access
- 1 April 2019
- Published by "MedINK" Publishing House in Andrology and Genital Surgery
- Vol. 20 (1) , 43-54
Meiosis, spermatogenesis and ultrastructure of the basement membrane of seminiferous tubules in patients with azoospermia
Мейоз, сперматогенез и ультраструктура базальной мембраны семенных канальцев у пациентов с азооспермией
- 1 April 2019
- Published by "MedINK" Publishing House in Andrology and Genital Surgery
- Vol. 20 (1) , 43-54
Open AccessMeiosis, spermatogenesis and ultrastructure of the basement membrane of seminiferous tubules in patients with azoospermia
Мейоз, сперматогенез и ультраструктура базальной мембраны семенных канальцев у пациентов с азооспермией
- Open Access
- 14 August 2018
- Published by "MedINK" Publishing House in Andrology and Genital Surgery
- Vol. 19 (2) , 40-51
GENETIC FACTORS OF MALE INFERTILITY, THEIR COMBINATIONS AND THE SPERMATOLOGICAL CHARACTERISTICS OF MEN WITH FERTILITY FAILURES
The objective is to study the occurrence of common genetic factors of male infertility in men with reproductive problems, their combinations and spermatological characteristics. Materials and methods . 393 men with infertility in marriage were examined. According to the results of the cytogenetic study, the sample is divided into 3 groups: 135 men with numerical sex chromosome abnormalities; 58 male patients with a balanced structural rearrangement; 200 men with normal karyotype. Y chromosome microdeletions, CFTR gene mutations and CAG-repeats polymorphism of AR gene were analyzed. Results . The Y-chromosome microdeletions partially AZFc deletions were detected in 13 % male patients with sex chromosome abnormalities. A combination of chromosomal abnormalities with AZF deletions and/or CFTR gene mutations and long CAG repeats of AR gene was found in 19 % infertile men with balanced chromosome rearrangements. Infertile men with normal male karyotype presented the frequency of common genetic factors of male infertility was almost 2 times higher than the combined frequency of these factors in groups of patients with chromosomes abnormalities. Azoospermia in men with normal karyotype and patients with chromosome abnormalities was diagnosed with the same frequency (58 %). In all men who have identified the presence of two or more genetic factors of male infertility, severe forms of pathozoospermia (azoospermia and severe oligozoospermia) were found. Conclusion . The combination of genetic factors of male infertility is accompanied by severe forms of pathozoospermia that indicates a possible additive effect of negative effect on spermatogenesis and male fertility.
- 14 August 2018
- Published by "MedINK" Publishing House in Andrology and Genital Surgery
- Vol. 19 (2) , 40-51
Open AccessGENETIC FACTORS OF MALE INFERTILITY, THEIR COMBINATIONS AND THE SPERMATOLOGICAL CHARACTERISTICS OF MEN WITH FERTILITY FAILURES
The objective is to study the occurrence of common genetic factors of male infertility in men with reproductive problems, their combinations and spermatological characteristics. Materials and methods . 393 men with infertility in marriage were examined. According to the results of the cytogenetic study, the sample is divided into 3 groups: 135 men with numerical sex chromosome abnormalities; 58 male patients with a balanced structural rearrangement; 200 men with normal karyotype. Y chromosome microdeletions, CFTR gene mutations and CAG-repeats polymorphism of AR gene were analyzed. Results . The Y-chromosome microdeletions partially AZFc deletions were detected in 13 % male patients with sex chromosome abnormalities. A combination of chromosomal abnormalities with AZF deletions and/or CFTR gene mutations and long CAG repeats of AR gene was found in 19 % infertile men with balanced chromosome rearrangements. Infertile men with normal male karyotype presented the frequency of common genetic factors of male infertility was almost 2 times higher than the combined frequency of these factors in groups of patients with chromosomes abnormalities. Azoospermia in men with normal karyotype and patients with chromosome abnormalities was diagnosed with the same frequency (58 %). In all men who have identified the presence of two or more genetic factors of male infertility, severe forms of pathozoospermia (azoospermia and severe oligozoospermia) were found. Conclusion . The combination of genetic factors of male infertility is accompanied by severe forms of pathozoospermia that indicates a possible additive effect of negative effect on spermatogenesis and male fertility.